Preliminary clinical trials and clinical pharmacologic studies with 5-(3,3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196) given orally.

C. L. Vogel, V. T. DeVita, C. Denham, H. T. Foley, R. B. Field, P. P. Carbone

Research output: Contribution to journalArticle

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)159-165
Number of pages7
JournalCancer chemotherapy reports. Part 1
Volume55
Issue number2
StatePublished - Apr 1 1971
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this